Broncho-Vaxom for children, capsules 3.5mg 10 pcs

Broncho-Vaxom for children stimulates the immune defense of the body and increases resistance to infections of the respiratory system.

Immunopharmacological studies have shown that Broncho-Vaxom children has the following effects:

• Enhances the formation of immunoglobulin A (IgA) secreted by airway mucosa and saliva.
• Enhances the number of circulating T-lymphocytes.

Clinically, Broncho-Vaxom for children reduces the frequency of acute respiratory tract infections, reduces the duration of their course, and reduces the likelihood of exacerbations of chronic bronchitis.

The necessity of other medicines, especially antibiotics is decreased.

Indications

For children aged 6 months to 12 years:

Active ingredient

Composition

Solid gelatin capsules, size #3, cap blue opaque, body white opaque; capsule contents – powder of light beige color.

How to take, the dosage

Broncho-Vaxom® for children is administered in children from 6 months to 12 years of age.

To treat: 1 capsule of Broncho-Vaxom® for children daily in the morning on an empty stomach until disappearance of symptoms, but not less than 10 days. If antibiotic therapy is necessary Broncho-Vaxom® for children should be taken in combination with antibiotic from the beginning of treatment.

The duration of treatment or the prescription of repeated therapy should be determined by a physician, based on the patient’s state of health.

In order to prevent exacerbations and supportive therapy: 1 capsule of Broncho-Vaxom® for children daily in the morning on an empty stomach. The course includes 3 cycles; each cycle consists of taking 1 capsule daily for 10 days; the interval between the cycles is 20 days.

If the capsule is difficult to swallow, open it and mix the contents with a drink (including fruit juice and milk).

Interaction

Broncho-Vaxom® for children can be used simultaneously with other medicinal products for therapy of acute and chronic respiratory diseases.

Interaction of the drug Broncho-Vaxom® for children with other medicinal products has not yet been established.

Special Instructions

Based on available data, it is not recommended to prescribe Broncho-Vaxom® Pediatric in children less than 6 months of age because of the immaturity of their immune system.

In order to avoid overdose, do not use the drug in capsules intended for adults (Broncho-Vaxom® Adult 7 mg capsules).

Impact on driving and operating machinery

Broncho-Vaxom® Pediatric does not affect the ability to drive vehicles and operate machinery.

Contraindications

Hypersensitivity to the components of the drug.

Side effects

Broncho-Vaxom® for children is usually well tolerated. The results of clinical studies indicate that the incidence of mild adverse reactions is 3-4%.

Digestive system disorders: nausea, abdominal pain, vomiting.

Dermatological reactions: itching, erythema.

Respiratory system: cough, shortness of breath.

Nervous system disorders: headache, feeling of fatigue.

In case of continuing gastrointestinal disorders, skin reactions and respiratory manifestations, the drug should be stopped, because they may be allergic reactions. In such a situation, it is necessary to consult with the attending physician.

Overdose

There are no reports of overdose.

The nature of the drug Broncho-Vaxom® for children and the results of its toxicity study indicate that overdose is unlikely.

Pregnancy use

The drug is contraindicated in children under 6 months.

Similarities